{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":30,"description":"The conjugate vaccine for Streptococcus pneumoniae will be administered during weeks 9, 17, and 25 after autologous HSCT - the study nurse will arrange for the vaccine to be administered at the specified time and the patient will be instructed to notify an investigator or study nurse of any side effects of vaccine administration. Streptococcus pneumoniae: Patients will receive 0.5 mL Prevnar in the deltoid muscle during weeks 9, 17, and 25 after autologous hematopoietic stem cell transplantation (HSCT)","id":"EG000","otherNumAffected":30,"otherNumAtRisk":30,"seriousNumAffected":0,"seriousNumAtRisk":30,"title":"Prevnar"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Upper Respiratory Infection","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE version 3.0","stats":[{"groupId":"EG000","numAffected":23,"numAtRisk":30,"numEvents":23}],"term":"Infection with unknown ANC"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Pneumo fever with origin unknown","organSystem":"Infections and infestations","sourceVocabulary":"CTCAE version 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30,"numEvents":3}],"term":"Infection with unknown ANC"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE version 3.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":30,"numEvents":3}],"term":"Fever with unknown origin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE version 3.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":30,"numEvents":2}],"term":"Colitis"}]}